» Articles » PMID: 15288443

Amyloid Beta-protein Induced Electrophysiological Changes Are Dependent on Aggregation State: N-methyl-D-aspartate (NMDA) Versus Non-NMDA Receptor/channel Activation

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2004 Aug 4
PMID 15288443
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease, however, the underlying mechanism driving this condition is unknown. Unexplored is the possibility that the time-dependent generation of different Abeta assemblies may underlie the pathogenic cascade with biophysically distinct structures interacting with unique biological targets. Thus, the presence of subtle alterations in synaptic function during the earliest clinical phase of AD may be mediated by diffusible assemblies of the amyloid beta-protein (Abeta). Using primary neocortical cultures, here we compare the synaptic responses induced by two different Abeta assemblies, protofibrils (PFs) and fibrils (FBs), and demonstrate for the first time that neuronal activation was selectively dependent on the assembly state of Abeta. PF-induced activity was specifically attenuated by the N-methyl-D-aspartate (NMDA) receptor antagonist, D-APV. In contrast, the non-NMDA glutamate receptor antagonist, NBQX, preferentially reduced FB-induced activity. In support, removal of Mg(2+) from the medium, which enhances NMDA channels, increased both PF- or FB-induced activation, but D-APV was more effective in attenuating PF-induced excitatory activity. These findings suggest that PFs may activate neurons differently than fibrils and lend support to the hypothesis that pre-fibrillar assemblies of Abeta may play an important role in the development of AD-type synaptic deficits.

Citing Articles

Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.

Martin Flores N, Podpolny M, McLeod F, Workman I, Crawford K, Ivanov D Elife. 2024; 12.

PMID: 38285009 PMC: 10945611. DOI: 10.7554/eLife.89453.


Pathophysiological Ionotropic Glutamate Signalling in Neuroinflammatory Disease as a Therapeutic Target.

Fairless R, Bading H, Diem R Front Neurosci. 2021; 15:741280.

PMID: 34744612 PMC: 8567076. DOI: 10.3389/fnins.2021.741280.


d-glutamate and Gut Microbiota in Alzheimer's Disease.

Chang C, Lin C, Lane H Int J Mol Sci. 2020; 21(8).

PMID: 32290475 PMC: 7215955. DOI: 10.3390/ijms21082676.


The Paroxysmal Depolarization Shift: Reconsidering Its Role in Epilepsy, Epileptogenesis and Beyond.

Kubista H, Boehm S, Hotka M Int J Mol Sci. 2019; 20(3).

PMID: 30699993 PMC: 6387313. DOI: 10.3390/ijms20030577.


Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Wang R, Reddy P J Alzheimers Dis. 2016; 57(4):1041-1048.

PMID: 27662322 PMC: 5791143. DOI: 10.3233/JAD-160763.